| Literature DB >> 25528859 |
Yasumori Izumi1, Hayato Takeshita1, Yuji Moriwaki2, Keiko Hisatomi3, Masakazu Matsuda1, Natsuki Yamashita1, Chieko Kawahara1, Yoshika Shigemitsu1, Nozomi Iwanaga1, Atsushi Kawakami4, Hirokazu Kurohama5, Daisuke Niino5, Masahiro Ito5, Kiyoshi Migita1.
Abstract
A 50-year-old woman was referred to our hospital for shoulder joint stiffness. She had a history of polyclonal hypergammaglobulinemia and an elevated C-reactive protein level. Her laboratory data revealed an elevated serum immunoglobulin G4 (IgG4) level, hypergammaglobulinemia, and rheumatoid factor positivity in the absence of anticyclic citrullinated peptide antibody. [18F]-Fluorodeoxyglucose positron emission tomography showed significant [18F]-fluorodeoxyglucose uptake in multiple lymph nodes (axillary, hilar, para-aortic, and inguinal). Biopsy of the inguinal lymph node showed expansion of the interfollicular areas by heavily infiltrating plasma cells, consistent with multicentric Castleman disease (MCD). Immunohistochemical analysis revealed a 37.3% IgG4-positive:IgG-positive plasma cell ratio, indicating overlapping IgG4-related disease. However, serological cytokine analysis revealed elevated levels of interleukin-6 (9.3 pg/ml) and vascular endothelial growth factor (VEGF) (1210 pg/ml), which are compatible with MCD. Corticosteroid treatment resolved the serological and imaging abnormalities. IgG4-related disease can mimic MCD, and it is crucial to distinguish between these two diseases. Serum interleukin-6 and VEGF levels may help to discriminate MCD from IgG4-related disease.Entities:
Keywords: IgG4-related disease; Interleukin-6; Multicentric Castleman disease
Mesh:
Substances:
Year: 2014 PMID: 25528859 DOI: 10.3109/14397595.2014.985356
Source DB: PubMed Journal: Mod Rheumatol ISSN: 1439-7595 Impact factor: 3.023